Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
<p>There is currently a need for vaccine adjuvants that are effective for eliciting Th1-type CD4 and CD8 T cell responses when formulated with protein and peptide-based subunit vaccines. Some of the most promising adjuvants in this regard are combined small molecule Toll-like receptor-7/8 agon...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Language: | English |
Published: |
2014
|
Subjects: |
_version_ | 1826290720051298304 |
---|---|
author | Lynn, G |
author2 | Seymour, L |
author_facet | Seymour, L Lynn, G |
author_sort | Lynn, G |
collection | OXFORD |
description | <p>There is currently a need for vaccine adjuvants that are effective for eliciting Th1-type CD4 and CD8 T cell responses when formulated with protein and peptide-based subunit vaccines. Some of the most promising adjuvants in this regard are combined small molecule Toll-like receptor-7/8 agonists (TLR-7/8a). However, poor pharmacokinetic properties have precluded TLR-7/8a for use in vaccines.</p> <p>In this thesis, polymer carriers were used to control pharmacokinetics and to modulate activity of TLR-7/8a for use as vaccine adjuvants. Combinatorial synthesis and <em>in vivo</em> structure-activity studies were used to evaluate how properties of Polymer-TLR-7/8a conjugates (Poly-7/8a) influence innate immune activation in lymph nodes that drain the site of vaccine administration. The most striking finding was that particle formation by Poly-7/8a strongly enhances the magnitude and duration (>14 days) of innate immune activation in lymph nodes by restricting agonist biodistribution and promoting uptake by dendritic cells. Particle-forming Poly-7/8a optimized for activity were found to induce only local innate immune activation (not systemic) and were effective for eliciting Th1-type CD4 and CD8 T cells that mediated protection against infectious challenge. Based on the importance of particle formation for activity of Poly-7/8a, thermo-responsive Poly-7/8a were developed that exist as single water-soluble macromolecules in solution but undergo temperature-driven particle formation <em>in vivo</em>. In conclusion, polymer carriers of TLR-7/8a represent a versatile and effective platform for modulating innate immune activity and warrant further investigation as a class of adjuvants for vaccines.</p> |
first_indexed | 2024-03-07T02:48:30Z |
format | Thesis |
id | oxford-uuid:acdb09f7-e690-4cf2-b0e4-3b1611750e49 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T02:48:30Z |
publishDate | 2014 |
record_format | dspace |
spelling | oxford-uuid:acdb09f7-e690-4cf2-b0e4-3b1611750e492022-03-27T03:31:41ZPolymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvantsThesishttp://purl.org/coar/resource_type/c_db06uuid:acdb09f7-e690-4cf2-b0e4-3b1611750e49VaccinologyAdvanced materialsChemistry & allied sciencesPolymers Amino acid and peptide chemistryChemical biologyMaterials SciencesSupramolecular chemistryImmunologyNano-biotechnologyNanomaterialsEnglishOxford University Research Archive - Valet2014Lynn, GSeymour, L<p>There is currently a need for vaccine adjuvants that are effective for eliciting Th1-type CD4 and CD8 T cell responses when formulated with protein and peptide-based subunit vaccines. Some of the most promising adjuvants in this regard are combined small molecule Toll-like receptor-7/8 agonists (TLR-7/8a). However, poor pharmacokinetic properties have precluded TLR-7/8a for use in vaccines.</p> <p>In this thesis, polymer carriers were used to control pharmacokinetics and to modulate activity of TLR-7/8a for use as vaccine adjuvants. Combinatorial synthesis and <em>in vivo</em> structure-activity studies were used to evaluate how properties of Polymer-TLR-7/8a conjugates (Poly-7/8a) influence innate immune activation in lymph nodes that drain the site of vaccine administration. The most striking finding was that particle formation by Poly-7/8a strongly enhances the magnitude and duration (>14 days) of innate immune activation in lymph nodes by restricting agonist biodistribution and promoting uptake by dendritic cells. Particle-forming Poly-7/8a optimized for activity were found to induce only local innate immune activation (not systemic) and were effective for eliciting Th1-type CD4 and CD8 T cells that mediated protection against infectious challenge. Based on the importance of particle formation for activity of Poly-7/8a, thermo-responsive Poly-7/8a were developed that exist as single water-soluble macromolecules in solution but undergo temperature-driven particle formation <em>in vivo</em>. In conclusion, polymer carriers of TLR-7/8a represent a versatile and effective platform for modulating innate immune activity and warrant further investigation as a class of adjuvants for vaccines.</p> |
spellingShingle | Vaccinology Advanced materials Chemistry & allied sciences Polymers Amino acid and peptide chemistry Chemical biology Materials Sciences Supramolecular chemistry Immunology Nano-biotechnology Nanomaterials Lynn, G Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants |
title | Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants |
title_full | Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants |
title_fullStr | Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants |
title_full_unstemmed | Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants |
title_short | Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants |
title_sort | polymer carriers of toll like receptor 7 8 agonists as vaccine adjuvants |
topic | Vaccinology Advanced materials Chemistry & allied sciences Polymers Amino acid and peptide chemistry Chemical biology Materials Sciences Supramolecular chemistry Immunology Nano-biotechnology Nanomaterials |
work_keys_str_mv | AT lynng polymercarriersoftolllikereceptor78agonistsasvaccineadjuvants |